Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International PublicationsIntroduction of adhesive and costimulatory immune functions into tumor cells by infection with Newcastle Disease Virus
/in International Publications, Newcastle Disease VirusA 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire
/in International Publications, Malignant Melanoma, Newcastle Disease VirusDendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice
/in Chronic Virus Hepatitis, International Publications[Current methods of radiation therapy in patients with prostatic cancer: subtotal body radiation, local hyperthermia]
/in Hyperthermia, International Publications, Prostate CancerPulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice
/in Dendritic Cells, International Publications, Soft Tissue SarcomaInduction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA
/in Colorectal Cancer, Dendritic Cells, International PublicationsExtracorporeal whole body hyperthermia treatment of HIV patients, a feasibility study
/in HIV/AIDS, International PublicationsFollow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides
/in Dendritic Cells, International Publications, Prostate Cancer
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer